A study led by scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has uncovered a key player contributing to the maintenance of hematopoietic stem cells ...
Feb 17, 2016
0
5
A team of researchers led by scientists at St. Jude Children's Research Hospital is looking at ways to improve how blood-forming stem cells can be used for therapeutic interventions. The work has uncovered a group of genes ...
Feb 16, 2016
0
1
After a long series of experiments, researchers at the Stanford University School of Medicine have identified a unique cell marker that they say allows them to pick out the most fundamental form of the stem cell that gives ...
Feb 11, 2016
0
53
Ayami Yoshimi, M.D., Ph.D., of the University of Freiburg, Germany, and colleagues examined the use of peripheral blood stem cells and bone marrow as stem cell sources for hematopoietic stem cell transplantation in patients ...
Jan 12, 2016
0
3
A study directed by Paul Frenette, M.D., is featured on the cover of today's print edition of Science. In experiments involving mice, Dr. Frenette and his colleagues have solved a mystery surrounding the development of hematopoietic ...
Jan 11, 2016
0
2
A study by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) has identified a new mechanism through which hematopoietic stem cells (HSCs) control both their own proliferation and the ...
Jan 8, 2016
0
12
Among adults with difficult to treat Crohn disease not amenable to surgery, hematopoietic stem cell transplantation, compared with conventional therapy, did not result in significant improvement in sustained disease remission ...
Dec 15, 2015
0
0
A particular location in DNA, called the Dlk1-Gtl2 locus, plays a critical role in protecting hematopoietic, or blood-forming, stem cells—a discovery revealing a critical role of metabolic control in adult stem cells, and ...
Nov 25, 2015
0
72
FUJIFILM Corporation today announced to conduct a clinical trial of its anti-cancer drug FF-10101 in patients with relapsed or refractory acute myeloid leukemia (AML) in the United States next year. FF-10101 is a new drug ...
Nov 10, 2015
0
13
More than 40 percent of older patients with acute myeloid leukemia (AML) can remain in long-term cancer remission through a modified, less aggressive approach to donor stem cell transplantation, according to the results of ...
Nov 4, 2015
0
11
